Ontology highlight
ABSTRACT: Purpose
Accumulation of PIK3CA, ESR1, and GATA3 mutations results in resistance to endocrine therapy in breast cancer patients; however, the response of these genes to chemotherapy is unclear. Therefore, we sought to evaluate the genetic response of circulating tumor DNA (ctDNA) to chemotherapy in metastatic breast cancer patients.Methods
The mutation frequency of 1021 genes was examined prior to chemotherapy in ctDNA of 44 estrogen receptor-positive metastatic breast cancer patients. These genes were evaluated again in a subset of patients (n=24) following chemotherapy. Mutation frequency was defined as the percentage of mutations found in ctDNA compared to total cell-free DNA.Results
Prior to chemotherapy, PIK3CA was the most commonly mutated gene, with mutation f
SUBMITTER: Zhou D
PROVIDER: S-EPMC6423490 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature